ANGPTL3 expression and serum levels could act as novel biomarkers in the diagnosis of chronic hepatitis and HCC, and ANGPTL3 expression could be useful for discriminating HCC from chronic hepatitis in patients (El-Shal et al., 2017). This evidence concerns the gene ANGPTL3 and hepatocellular carcinoma.